Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Rare Diseases 2021

About the Conference

World Congress on Infectious Diseases and Rare Diseases is the main gathering where you can find out about Infectious Diseases and Rare Diseases from an assortment of points of view, both research-based and clinical. We will examine the freshest remedial methods and analytic devices just as the most exceptional research on hereditary, aetiology, indicative, clinical viewpoints and novel treatments of Infectious sicknesses. Worldwide Infections and Rare Disease Conferences furnishes an opportunity to work together with industry peers and find learning and assets that can be utilized to accomplish your own and authoritative objectives .

Why to attend?

Rare Diseases 2021 is a stage for, (Doctors, doctors, look into researchers, understudies, modern and Pharma experts) to uncover their examination work, to Share their insight in Infectious, Rare Diseases sicknesses. It is a chance to communicate with individuals over the globe concentrated on finding out about Infectious. Incredibly famous speakers, the latest treatments and the most recent updates in Rare and Infectious Diseases are signs of this meeting.

 

Target Audience:

• Irresistible Disease

• Allergists

• Immunologists

• Microbiologists

• Pediatricians

• Physicians

• Academicians

• Health Care experts

• Young Research Scholars

• Students

• Society and Organizational Members

 

 

Sessions/Tracks

Track 1: Different types of Rare Diseases

A rare disease is defined as a condition that affects less than 200,000 people. This explanation was formed by Congress in the Orphan Drug Act of 1983. There may be as many as 7,000 rare diseases. Only a few categories of rare diseases are tracked when a person is diagnosed. These include certain infectious diseases, birth defects, and cancers. It also comprises the diseases on state newborn screening tests. Because most rare diseases are not trailed, it is hard to determine the exact number of rare diseases. Most rare diseases are genetic, and thus are present throughout the person's intact life, even if symptoms do not immediately appear.

Track 2: Rare Infectious Diseases and Immune Deficiencies

Globally, about one-third of human deaths are attributable to infections. In addition, the so-called non-infectious causes of death often have a mysterious infectious etiology. Many rare diseases or orphan diseases caused by infectious agents rather than genetic or environmental factors.

Track 3: Rare Diseases in Cancer

Rare cancers caused by simple genetic mutations and common cancers tend to be caused by a complex set of genetic and epigenetic aberrations that continually grow in number as the tumor develops. A cancer is considered to be rare if- 1. It starts in an uncommon place in the body, 2. The cancer is an unusual type and may need special treatment, 3. It is not one of the common types of cancer.

Track 4: Recent emerging infectious diseases

An emerging infectious disease (EID) is a contagious disease whose occurrence has boosted in the last 50 years and chances are there that it could increase in the coming future. Emerging infections account for at least 15% of all human pathogens. EIDs are caused by freshly identified strains that may have emerged from a known infection or transferred to a new community or to a field undergoing conserves metamorphosis, or remerging infections. Of thriving concern are adverse synergistic communication between emerging diseases and other infectious and non-infectious conditions ruling to the evolution of unusual syndemics. Many emerging diseases are zoonotic or synoptic - an animal receptacle incubates the organism, with only random conveyance into human populations. Infectious Diseases square amplitude ataxia caused by microorganism such as viruses, fungi or parasites. Infectious diseases is also, foodborne, vector borne, air borne in  related as  further more  in plants and animals. They essentially affirm on the pathological approach of the microorganism and their therapeutic amplifications, synthesis of division of particularly clinical and diagnostic biology that deals with the cure endurance of the contagious diseases. It exemplifies associate degree progressively mandatory for human pessimism and fatality reason throughout the map.

Track 5: Viral Infectious Diseases

Viral Infectious Disease occurs when an organism's body is invaded by pathogenic viruses, and infectious virus particles (virions) attach to and enter susceptible cells. There are many types of viruses that cause a wide variety of viral diseases. The most common type of viral disease is the common cold, which is caused by a viral infection of the upper respiratory tract (nose and throat). Viral diseases are contagious and spread from person to person when a virus enters the body and begins to multiply. Viral diseases result in a wide variety of symptoms that vary in character and severity depending on the type of viral infection and other factors, including the person’s age and overall health.

Track 6: Sexually transmitted diseases

Sexually transmitted infections (STIs), also referred as venereal diseases (VD), are infections that are generally disseminated by sex, especially vaginal coition, anal sex or oral sex. Most STIs originally do not cause symptoms. This leads to a greater risk of transferring the disease on to others. Expression and evidences of disease may include vaginal discharge, penile discharge, ulcers on or around the genitals, and pelvic pain. STIs attained before or during birth may result in poor fallout for the baby. Some STIs may cause problems with the capacity to conceive. More than 100 different microbial pathogen can cause STIs. Bacterial STIs include chlamydia, gonorrhea, and syphilis among others. Viral STIs include genital herpes, HIV/AIDS, and genital warts among others. Parasitic STIs comprises trichomoniasis among others. While usually spread by sex, some of them can also be spread by non-sexual influence with infected blood and tissues, breastfeeding, or during childbirth. STI assay tests are easily available in the developed world. Most STIs are amenable. Of the most common infections, syphilis, gonorrhea, chlamydia, are curable, while herpes, hepatitis B, HIV/AIDS, and HPV are treatable but not curable. Refusal to certain antibiotics is developing among some strains such as gonorrhea. Not all STIs are emblematic, and symptoms may not appear rapidly after infection. In some cases, a disease can be without any expression, which leaves higher chances of transmission of the disease on to others. Depending on the infection, some untreated STIs can lead to infertility, chronic pain or even death. The occurrence of an STI in prepubescent children may indicate sexual exploitation.

Track 7: COVID-19 and Impact on Healthcare

Effective implementation of measures like closing down schools, universities, workplaces, and mass get-togethers notwithstanding social separating, could diminish the quantity of cases fundamentally and hinder its encouraging two-three months sooner.

The model took a gander at adequacy with changing degrees of isolate. It can extend on essentially at low levels, for example, 20 percent isolate. The effect on development starts to set in when 50 percent or a greater amount of contaminated people are disengaged asqto forestall spread.

Track 8:  Paediatric infectious diseases

Pediatric infectious diseases are the contagious diseases which are caused in children of different age groups. Pediatric infectious diseases consultant takes care of the infections occurring in children and the curing approaches vary for children from adults. Spreading of diseases can be through direct contact like touching and indirect contact with the infected person. Droplet transmission is very common. Airborne spreading occurs when germs stay in the air and are carried around on air current.

Track 9: HIV/AIDS

HIV stands for Human immunodeficiency virus. It harms your immune system by destroying the white blood cells that fight infection. This puts you at risk for serious infections and certain cancers. AIDS stands for Acquired Immuno Deficiency Syndrome. It is the final stage of infection with HIV. Not everyone with HIV develops AIDS. People affected by this virus will be susceptible to opportunistic infection or susceptible to tumors. AIDS is the most severe phase of HIV infection.

Track 10: Challenges in Rare Diseases Treatment

There are around 7,000 rare diseases, which from a regulatory outlook are defined as those diseases where there are less than 200,000 patients in the US or that affect no more than five in 10,000 of the general population in the EU. Orphan drugs are medicinal products envisioned for diagnosis, prevention, and treatment of life-threatening rare diseases. They are "orphans" because the pharmaceutical industry has little interest under normal market conditions in developing and marketing drugs intended for only a small number of patients suffering from very rare conditions.

Track 11: Detection and Preventing Infections in healthcare

Healthcare-associated infections are a threat to patient safety. Hospitalization for an acute illness, trauma, chronic care, or other health care conditions is a common occurrence. There were 39.2 million hospital discharges in 2005, with an average length of stay of 4.6 days. Hospitalization brings associated risks, including risk of infection. Nosocomial infections, or hospital-associated infections, are estimated to occur in 5 percent of all acute care hospitalizations, or 2 million cases per year. Hospital-associated infections have been identified as one of the most serious patient safety issues in health care. Infections that become clinically evident after 48 hours of hospitalization are considered hospital-associated. Risks factors for hospital-associated infections are generally categorized into three areas: iatrogenic, organizational, or patient-related. Iatrogenic risk factors include invasive procedures (e.g., intubation, indwelling vascular lines, urine catheterization) and antibiotic use and prophylaxis. Organizational risk factors include such things as contaminated air-conditioning systems, contaminated water systems, staffing (e.g., nurse-to-patient ratio), and physical layout of the facility (e.g., open beds close together). Examples of patient-related risk factors include severity of illness, immunosuppression, and length of stay.

Track 12: Paediatric HIV Treatment Initiative

Retroviruses are pleiotropically found in animals. Two human retroviruses are especially important pathogens. These are the HIV and the human T-cell leukemia virus, HTLV. HIV causes AIDS while HTLV-I is the etiological agent for adult T-cell leukemia. There is a large amount of basic research being conducted on HIV and HTLV-I spanning gene expression, virus structure-assembly, integration, replication, and pathogenesis. Retro virology intends to cover areas of human and animal retrovirus research.

Track 13: Rare Infectious Diseases and Immune Deficiencies

Globally, about one-third of human deaths are attributable to infections. In addition, the so-called non-infectious causes of death often have a mysterious infectious etiology. Many rare diseases or orphan diseases caused by infectious agents rather than genetic or environmental factors.

Track 14: Preventing Mother-to-Child Transmission of HIV

Mother-to-child transmission of HIV is the spread of HIV from an HIV-infected woman to her child during pregnancy, childbirth (also called labor and delivery), or breastfeeding. Mother-to-child transmission of HIV is also called perinatal transmission of HIV. Mother-to-child transmission is the most common way that children become infected with HIV. The HIV medicine reduces the risk of infection from any HIV that may have entered a baby’s body during childbirth.

Track 15: Advancement in vaccine and therapeutics

The exploration of vaccines has led to the near elimination of several important diseases and has a great impact on health for a relatively low cost. However, most vaccines in use today were developed by techniques that were pioneered more than 50 years ago and do not represent the full potential of the field. The introduction of genetic engineering has triggered rapid proposal in vaccine technology and is now prominent to the entry of new products in the merchandise. Global immunization against certain diseases has led to the abolish of smallpox and has almost complete elimination of  many other infectious agents including those causing diphtheria, tetanus, poliomyelitis, measles, mumps, rubella, and Hemophilic influenza type B invasive disease. However, three biggest killers—human immunodeficiency virus (HIV) infection, tuberculosis, and malaria—have not yet been adequately concentrated by a vaccine effective enough to accomplish a similar result. In addition, some common vaccine-preventable diseases such as influenza and pertussis continue to cause significant anguishment and fatality. Current advances in vaccine technology deriving from the function of genetic engineering are now providing the liberty to target new diseases. The use of plasmid-based methods also has the capability to urge the production of reassortant vaccines.

 

Track 16: Blood stream infections or blood poisoning

Blood stream infections/ blood poisoning occurs when a bacterial infection elsewhere in the body such as in the lungs or skin which enters the blood stream. This is dangerous because the bacteria and their toxins can be carried through the blood stream to the entire body. It is a very serious condition that can lead to organ failure and even death. Blood poisoning requires immediate treatment. Unless it is treated quickly, the bacteria in the blood can cause sepsis. The symptoms of blood poisoning are similar to that of cold or of the flu.

Track 17: Urinary tract infections

Urinary tract infections are the infections which are observed in any part of the urinary system (kidneys, ureters, bladder and urethra). Mostly infections are observed in the lower urinary tract (bladder and urethra). Women are at greater risk than men. The most common cause of infection is Escherichia coli, though other bacteria or fungi may rarely be the cause. Risk factors include sexual intercourse, diabetes, obesity, and family history.

Track 18: Global trends in emerging infectious diseases

An Infectious disease whose occurrence has increased in the past decades or threatens to increase is termed as emerging. These diseases include new infections, previously unrecognized infections and old infections reappearing due to antimicrobial resistance, public health issues and unhygienic conditions.

Track 19: Market analysis and manufactures of infectious diseases

The market report formulate information from divergent origin into a tenacious unit that includes an overview, global assumption of infectious diseases, infectious diseases by type, diagnosis and cure, lime lighting pharmaceutical and diagnostic products, and an applicable patents section. Report is organized by type of infectious diseases and appropriate treatments, both recent and predictable. Global Market Reports of inevitable disabilities is a full investigation and stream inclines in the irresistible disorders remedial and indicative market, industry development drivers, triggered treatments and stipulations. It gives advertise bump to the coming years. It incorporates checking of late advancements in modernization for contamination assay and treatment. Market reports likewise incorporate an investigation of small scale and large scale variables important for the current market holders and new contestants side by side.

Track 20: Clinical Research and Public Awareness

Clinical research is a branch of healthcare science. The first step in confronting this challenge is regularly getting the community to think about participating in clinical research. People need to consider how they can help advance the prevention, diagnosis, and treatment of disease. It is never too early to consider contribution whether or not someone finally chooses to join a study.

Track 21: Bacterial Infectious Diseases

Bacteria are living things that have only one cell. Under a microscope, they look like balls, rods, or spirals. They are so small that a line of 1,000 could fit across a pencil eraser. Most bacteria won't hurt you - less than 1 percent of the different types make people sick. Many are helpful. Some bacteria help to digest food, destroy disease-causing cells, and give the body needed vitamins. Bacteria are also used in making healthy foods like yogurt and cheese. But infectious bacteria can make you ill. They reproduce quickly in your body. Many give off chemicals called toxins, which can damage tissue and make you sick. Examples of bacteria that cause infections include Streptococcus, Staphylococcus, and E. coli. Antibiotics are the usual treatment. When you take antibiotics, follow the directions carefully. Each time you take antibiotics, you increase the chances that bacteria in your body will learn to resist them causing antibiotic resistance. Later, you could get or spread an infection that those antibiotics cannot cure.

Track 22: Pediatric Infections/ Childhood Infections Prevention and Control

Pediatric infections/ childhood infections are the infections which are caused in children of different age groups. Pediatric infections specialist’s takes care of the infections occurring in children and the treatment methods vary for children from adults.

Track 23: Neonatal Intensive Care Unit/ New Born Intensive Care/ Intensive Care Nursery

A neonatal intensive care unit/ new born intensive care/ intensive care nursery is an intensive care unit specializing in the care of ill or premature new born infants.

 

Market Analysis

Market Analysis

Market investigation for Infectious and Rare Diseases 2021 !

Worldwide commercial center record of irresistible illnesses centers around the momentum inclines inside the irresistible infections helpful and demonstrative market, industry increment drivers, unrivaled treatment choices and restrictions. It gives commercial center projections to the moving toward years. It comprises of assessment of late patterns in age for disease guess and treatment. World Infectious and Rare Diseases Diagnostics Market is anticipated to surpass additional than US$ 21.00 Billion through 2022 at a CAGR of 10% inside the given gauge time frame. The overall market for irresistible sickness symptomatic, antibody, and cure items came to $108.4 billion out of 2015. Furthermore, the scope of $126.2 billion of every 2016 and $183.2 billion out of 2021, showing a compound yearly increment rate (CAGR) of 7.7% from 2016 to 2021.And the worldwide commercial center for best 6 irresistible affliction is required to reach USD 86.2 billion by method for 2025, in venture with another record with the guide of Grand View Research, Inc.

 

The commercial center is generally pushed by means of developing amount of Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV), TB, and hepatitis examples all inclusive. Government and private organizations are making a venture firmly inside the social insurance region to forestall, analyze, and manage irresistible illnesses; developing speculations for development of new tablets to treat irresistible ailments, and expanding amount of activities for developing insight about those conditions are foreseen to strengthen the market at some phase in the gauge length. Moreover, developing amount of patent lapses and access of conventional tablets inside the commercial center are relied upon to development the call for irresistible malady therapeutics because of their low expenses. Likewise, accessibility of pay for visualization and treatment of those diseases and loosened circulation of prescription by means of producers in regions with high occurrence of those disorders are factors additionally foreseen to push the commercial center blast. Be that as it may, low entrance charge of hostile to infective and accessibility of enormous wide assortment of fake medications are foreseen to restriction the commercial center blast for the term of the gauge length. A portion of the key patrons are Novartis AG, Gilead, GlaxoSmithKline %, Janssen Pharmaceutical, Inc., F

 

Infections related Associations worldwide:

Association for Professionals in Infection Control and Epidemiology

Centres for Disease Control and Prevention

Infectious Diseases Society of America

National Institute of Allergy and Infectious Diseases

World Health Organization

National Institute of Allergy and Infectious Diseases

Centres for Disease Control and Prevention

Directors of Health Promotion and Education

National Foundation for Infectious Diseases

National Institute of Allergy and Infectious Diseases

 

Top Hospitals across Global:

Nuffield Health Bristol Hospital – The Chesterfield – Bristol, U.K.

Upper River Valley Hospital – New Brunswick, Canada

Hackensack University Medical Centre – Hackensack, New Jersey

Legacy Salmon Creek Medical Centre – Portland, Washington

Wooridul Spine Hospital – Seoul, South Korea

Houston Methodist Hospital – Houston, Texas

Hartford Hospital – Hartford, Connecticut

University of Pittsburgh Medical Centre – Pittsburgh, Pennsylvania

University of Texas MD Anderson Cancer Centre – Houston, Texas

UCLA Health: Ronald Reagan UCLA Medical Centre – Los Angeles, California

Mercy San Juan Medical Centre – Carmichael, California

Massachusetts General Hospital – Boston, Massachusetts

Ramkhamhaengs Hospital – Bangkok, Thailand

The urbanization of the human people is on the peril of transmission of numerous irresistible advertisers. Right now, >80% of individuals live in developing nations, rising event of irresistible infirmities, developing use to upgrade the entrance cost of cures of these ailments, developing undertakings and making awareness around medicines and finding of those circumstances, and developing logical preliminary research for development of late pills are no doubt to be the components chargeable for blast of this commercial center. Nonetheless, absence of learning and medications for these disarranges and low appropriation of cures are elements to restriction the development in the coming years.

 

Major Universities on Infectious & Microbiology:

National University of Singapore

Nanyang Technological University

PSB Academy

Management Development Institute of Singapore

Nanyang Polytechnic

Singapore University of Technology and Design

Singapore Polytechnic

Ngee Ann Polytechnic

Republic Polytechnic

 

Pharma companies:

Beacons Pharmaceuticals Pte Ltd

iNova Pharmaceuticals (Singapore)

Sanofi - Aventis

Vifor Pharma

Astrazeneca Singapore Pte Ltd

CCM Pharmaceuticals (S) Pte Ltd

Aventis Pharma

Servier (s) Pte Ltd

Hyphens Pharma Pte. Ltd.

Pfizer

 

To Collaborate Scientific Professionals around the World

Conference Date September 20-21, 2021

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Journal of Infectious Diseases & Therapy Journal of Rare Disorders: Diagnosis & Therapy Clinical Microbiology: Open Access

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by